Committed to Patient Safety & Product Quality
At Life Infusion Pharmaceuticals, we are committed to monitoring the safety of our products. We encourage healthcare professionals, patients, and consumers to report any adverse events, product quality complaints, or suspected side effects associated with our products.
Please provide as much information as possible. All fields marked with * are mandatory.
Pharmacovigilance is the science and activities relating to the detection, assessment, understanding, and prevention of adverse effects or any other medicine-related problems. It plays a critical role in ensuring that medicines remain safe for patients throughout their lifecycle.
At Life Infusion Pharmaceuticals Private Limited, we have established a robust pharmacovigilance system to collect, evaluate, and report safety information in compliance with national and international regulatory requirements. Your reports contribute directly to improving patient safety and product quality.
Adverse Drug Reaction (ADR) & Drug Safety Reporting
CDSCO / PvPI Compliant | Schedule Y
Life Infusion Pharmaceuticals Pvt. Ltd. is committed to maintaining the highest standards of patient safety, product quality, and regulatory compliance. In accordance with the guidelines of the Central Drugs Standard Control Organisation (CDSCO) and the Pharmacovigilance Programme of India (PvPI), we operate a dedicated Pharmacovigilance (PV) system for the collection, assessment, monitoring, and reporting of Adverse Drug Reactions (ADRs), Serious Adverse Events (SAEs), and product quality concerns related to our IV fluid products.
Any unintended, harmful, or unexpected response associated with the use of our products:
Events resulting in:
Report issues such as:
Examples include:
Cases where the product does not achieve the intended clinical outcome.
| Event Type | Reporting Timeline | Submission Authority |
|---|---|---|
| Serious ADR (Fatal / Life-threatening) | Within 15 Calendar Days | CDSCO / PvPI |
| Serious ADR (Non-fatal) | Within 90 Calendar Days | CDSCO / PvPI |
| Non-serious ADR | Quarterly / Annual PSUR | CDSCO |
| Critical Product Quality Complaint | Within 3 Working Days (Internal) | QA Department + CDSCO |
| Periodic Safety Update Report (PSUR) | Annual Submission | CDSCO |
Use our portal. Acknowledged within 24 hours.
Send details to pv@lifeinfusionpharma.com
+91 87141 33663 (Mon–Sat, 9 AM – 5 PM)
Submit via official app directly to the national database.
Report through the national helpline.
Send completed CDSCO form to our office.
An ADR is a harmful or unintended reaction that occurs after using a medical product. It can be a side effect, allergic reaction, or other negative outcome linked to the medicine.
You can report through our online portal, by email to pv@lifeinfusionpharma.com, by phone, or via the PvPI mobile app. All reports are acknowledged and handled confidentially.
Absolutely. All personal data is protected in accordance with Indian regulations. Your identity is never disclosed without legal requirement.
Our pharmacovigilance team reviews your report. You will receive a ticket number for tracking. If more information is needed, we may contact you using the details provided.
Anyone: healthcare professionals, patients, caregivers, or consumers. We encourage all reports to improve product safety.
Yes. Product quality complaints (leakage, discolouration, particulate matter, etc.) are taken very seriously and should be reported immediately.
Pharmacovigilance Officer
Life Infusion Pharmaceuticals Pvt. Ltd.
+91 87141 33663
Kinalur, Kozhikode, Kerala, India
Registered under CDSCO / PvPI Compliance Framework.
All reports are handled with strict confidentiality. Personal information is protected under Indian regulations. Reporting in good faith will not result in any penalty or disadvantage. Identity details are not disclosed except where legally required.
Aligned with CDSCO guidelines & Schedule Y provisions.